FDA.reportPublic FDA data

Aquaflora Phase II

Manufacturer
King Bio Inc
Effective date
2026-10-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-10-07 01:01:52

Label at a glance#

ProductAquaflora Phase II
Active ingredientCANDIDA ALBICANS
Label structure9 sections

Indications and uses

for temporary relief of Candida albicans overgrowth symptoms, such as: reactions on skin thick, dry, and cracked tongue bad breath dry lips and mouth constipation eczema

Dosage and administration

Adults(12 & up): Two tablespoons daily on an empty stoach, 20 minutes before breakfast Children(ages 2-12): One tablespoon daily under the direct supervision of a physician.

Label contents#

Full prescribing information#

HPUS ​Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Candida albicans

​Uses

INDICATIONS & USAGE SECTION

for temporary relief of Candida albicans overgrowth symptoms, such as:

  • reactions on skin
  • thick, dry, and cracked tongue
  • bad breath
  • dry lips and mouth
  • constipation
  • eczema

​Warnings

WARNINGS SECTION

  • ​If symptoms persist or worsen, ​seek advice of a physician.
  • ​If pregnant or breast-feeding, ​ask a heathcare professional before use. 

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

​Keep out of reach of children

​Directions

DOSAGE & ADMINISTRATION SECTION

Adults(12 & up): Two tablespoons daily on an empty stoach, 20 minutes before breakfast

Children(ages 2-12): One tablespoon daily under the direct supervision of a physician.

​Purpose

OTC - PURPOSE SECTION

for temporary relief of Candida albicans

​Other Information

OTHER SAFETY INFORMATION

Tamper resistant for your protection. Use only if safety seal is intact

​Inactive Ingredients

INACTIVE INGREDIENT SECTION

Bio-Energetically Enhanced pure water, Carya ovata bark extract (hickory), citrus extract, Lonicera japonica (honeysuckle), polylysine (natural ferment), steviol glycosides (stevia)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
57955-1602-62020-01-31C16284748780-19d75b9d0-2431-f424-e053-dadaa90a57ceAquaflora Phase II
57955-1602-62020-01-31C16284748780-19d75b9d0-2431-f424-e053-dadaa90a57ceAquaflora Phase II

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57955-160257955-1602-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
NameUNIIKind
CANDIDA ALBICANS4D7G21HDBCACTIB
WATER059QF0KO0RIACT
CARYA OVATA BARKX765CF609LIACT
CITRUS BIOFLAVONOIDSBD70459I50IACT
LONICERA JAPONICA FLOWER4465L2WS4YIACT
POLYEPSILON-LYSINE (4000 MW)WB0M8X4TWRIACT
REBAUDIOSIDE AB3FUD0528FIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12018-04-03full-release2026-06-01 02:09:18

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3502d916-7322-4cd5-8fe2-d53a14663f205da0d84c-afed-4c64-a629-4a16dfba273e2018-04-03WarningsExact identifier
spl set id: 5da0d84c-afed-4c64-a629-4a16dfba273e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.